Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 1, 1977
The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man
D S Schade, R P Eaton
Diabetes
|
November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability
D S Schade, R P Eaton
Diabetes
|
May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics
D S Schade, R P Eaton
Diabetes
|
January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulin
D S Schade, R P Eaton
Hospital Practice (1995)
|
December 15, 1996
Diabetes mellitus: 2. Managing type II disease
M R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1975
Altered tissue response to glucagon in obesity
D S Schade, R P Eaton
Clinics in Endocrinology and Metabolism
|
July 1, 1983
Diabetic ketoacidosis--pathogenesis, prevention and therapy
D S Schade, R P Eaton
Diabetes
|
October 1, 1977
The regulation of plasma ketone body concentration by counterregulatory hormones in man
D S Schade, R P Eaton
Acta Diabetologica Latina
|
January 1, 1977
Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man
D S Schade, P R Eaton
Metabolism: Clinical and Experimental
|
May 1, 1974
Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man
R P Eaton, D S Schade
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 1, 1977
The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man
D S Schade, R P Eaton
Diabetes
|
November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability
D S Schade, R P Eaton
Diabetes
|
May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics
D S Schade, R P Eaton
Diabetes
|
January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulin
D S Schade, R P Eaton
Hospital Practice (1995)
|
December 15, 1996
Diabetes mellitus: 2. Managing type II disease
M R Burge, D S Schade
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1975
Altered tissue response to glucagon in obesity
D S Schade, R P Eaton
Clinics in Endocrinology and Metabolism
|
July 1, 1983
Diabetic ketoacidosis--pathogenesis, prevention and therapy
D S Schade, R P Eaton
Diabetes
|
October 1, 1977
The regulation of plasma ketone body concentration by counterregulatory hormones in man
D S Schade, R P Eaton
Acta Diabetologica Latina
|
January 1, 1977
Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man
D S Schade, P R Eaton
Metabolism: Clinical and Experimental
|
May 1, 1974
Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man
R P Eaton, D S Schade
Page
of 13